← All organizations

Abivax S.A.

For profitWebsite ↗

Also known as: Abivax S.A.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Nov 30, 2022

Timeline

2010s

Jun 1, 2013
Abivax S.A.— Founded

Drugs by trial phase (5 distinct, 21 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

caffeine

Indications

Studied for

Recent trials (27)

NCT05507216Lead sponsorPhase 3Nov 30, 2022
NCT05535946Lead sponsorPhase 3Nov 30, 2022
NCT05507203Lead sponsorPhase 3Oct 10, 2022
NCT05177835Lead sponsorPhase 2Dec 3, 2021
NCT05032560Lead sponsorPhase 1Sep 27, 2021
NCT05121714Study directorPhase 1Dec 17, 2020
NCT05121714Lead sponsorPhase 1Dec 17, 2020
NCT04393038Lead sponsorPhase 2/Phase 3May 1, 2020
NCT04023396Lead sponsorPhase 2Oct 31, 2019
NCT04049448Study directorPhase 2Oct 24, 2019
NCT04049448Lead sponsorPhase 2Oct 24, 2019
NCT03905109Lead sponsorPhase 2Jul 1, 2019
NCT03897543Lead sponsorPhase 1/Phase 2Jul 1, 2019
NCT03813199Lead sponsorPhase 2Jun 30, 2019
NCT03813199Study directorPhase 2Jun 30, 2019

Details

Founded: Paris, FR Jun 1, 2013
Last known activity: Nov 30, 2022